Trexquant Investment’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$8.54M Sell
234,912
-33,754
-13% -$1.23M 0.1% 309
2025
Q1
$9.73M Buy
268,666
+112,010
+72% +$4.06M 0.11% 260
2024
Q4
$6.59M Sell
156,656
-10,611
-6% -$446K 0.08% 415
2024
Q3
$9.29M Buy
167,267
+148,502
+791% +$8.25M 0.12% 258
2024
Q2
$771K Sell
18,765
-44,398
-70% -$1.82M 0.01% 1092
2024
Q1
$2.95M Buy
63,163
+9,663
+18% +$451K 0.06% 505
2023
Q4
$2.56M Buy
53,500
+23,952
+81% +$1.15M 0.06% 471
2023
Q3
$1.05M Buy
29,548
+668
+2% +$23.8K 0.03% 733
2023
Q2
$1.33M Buy
28,880
+4,707
+19% +$217K 0.03% 660
2023
Q1
$969K Sell
24,173
-19,834
-45% -$795K 0.03% 743
2022
Q4
$2.04M Buy
44,007
+19,703
+81% +$913K 0.06% 406
2022
Q3
$1.01M Buy
24,304
+2,316
+11% +$95.9K 0.04% 531
2022
Q2
$1.31M Buy
21,988
+9,853
+81% +$588K 0.06% 406
2022
Q1
$881K Buy
+12,135
New +$881K 0.04% 522
2021
Q3
Sell
-9,175
Closed -$875K 1420
2021
Q2
$875K Buy
+9,175
New +$875K 0.07% 337
2020
Q4
Sell
-5,120
Closed -$421K 1410
2020
Q3
$421K Sell
5,120
-6,279
-55% -$516K 0.03% 771
2020
Q2
$892K Buy
+11,399
New +$892K 0.06% 435
2019
Q3
Sell
-6,062
Closed -$385K 1072
2019
Q2
$385K Buy
+6,062
New +$385K 0.03% 536
2019
Q1
Sell
-11,852
Closed -$515K 1253
2018
Q4
$515K Buy
+11,852
New +$515K 0.03% 603
2018
Q3
Sell
-13,645
Closed -$1.05M 1149
2018
Q2
$1.05M Buy
+13,645
New +$1.05M 0.07% 364
2017
Q1
Sell
-3,600
Closed -$253K 1281
2016
Q4
$253K Sell
3,600
-3,200
-47% -$225K 0.04% 717
2016
Q3
$482K Sell
6,800
-27,465
-80% -$1.95M 0.11% 323
2016
Q2
$1.68M Buy
34,265
+30,168
+736% +$1.48M 0.22% 125
2016
Q1
$259K Sell
4,097
-4,903
-54% -$310K 0.03% 776
2015
Q4
$1.01M Buy
+9,000
New +$1.01M 0.09% 388
2015
Q1
Sell
-15,400
Closed -$675K 1149
2014
Q4
$675K Buy
+15,400
New +$675K 0.12% 322